chlorambucil has been researched along with BOOP in 1 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Excerpt | Relevance | Reference |
---|---|---|
"Chlorambucil was discontinued and an open lung procedure was performed with complete excision of the pulmonary lesion." | 2.42 | Bronchiolitis obliterans organizing pneumonia following chlorambucil treatment for chronic lymphocytic leukemia. ( Arkoumani, E; Kalambokis, G; Stefanou, D; Tsianos, E, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kalambokis, G | 1 |
Stefanou, D | 1 |
Arkoumani, E | 1 |
Tsianos, E | 1 |
1 review available for chlorambucil and BOOP
Article | Year |
---|---|
Bronchiolitis obliterans organizing pneumonia following chlorambucil treatment for chronic lymphocytic leukemia.
Topics: Aged; Biopsy; Chlorambucil; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Disease-Free | 2004 |